New Drug Candidate is Promising Therapeutic Option for Angiogenic Retinal Diseases
Beth Israel Lahey HealthResearchers have identified a small molecule that treats animal models of aged related macular degeneration and retinopathy of prematurity by preventing the overgrowth of blood vessels that are characteristic of these two retinal diseases.